Tokyo, June 26, 2007 (JCN Newswire) - Eisai Co., Ltd. announced today that an additional indication for Tambocor(R) Tablets 50 mg /100 mg (generic name: flecainide acetate) for the treatment of paroxysmal atrial fibrillation/flutter received approval in Japan.
